No profile data available.
Moderna, Inc. (MRNA) is a healthcare company in the antiviral pharmaceuticals industry, based in Cambridge, United States, with about 4,700 full-time employees.
It reported revenue of $1.92 billion for fiscal year 2025, down 39.9% from fiscal year 2024, and net income of -$2.82 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $143.00 million, up 4.4% from a year before. United States was its largest region in fiscal year 2025, with 62% of revenue. Its market capitalization was $89.83 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
Moderna reported $1.92 billion in revenue for fiscal year 2025, down 39.9% from $3.20 billion in fiscal year 2024. In Q2 2026 revenue was $143.00 million.
United States: 62% of revenue by region in fiscal year 2025, followed by Rest of World (36%).
$89.83 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Gilead Sciences, Inc. (GILD), BioNTech SE (BNTX), Novavax, Inc. (NVAX), Vir Biotechnology, Inc. (VIR).